Categories
Beta Drugs Limited — Updates, 25-05-2026: General Updates
25-05-2026 · 08:19 pm
BETA has completed the acquisition of 66.09% equity in Nivian Lifesciences, acquiring 10,94,535 shares. This makes Nivian a subsidiary. BETA will now seek NSE listing approval for the share swap arrangements.
No comments yet. Be the first to comment!